On March 3, Canada received an initial shipment of 500,000 doses of the AstraZeneca vaccine – under the brand name COVISHIELD – manufactured at the Serum Institute of India. While a total of 300,000 of those doses have an expiry date of April 2, the rest are good to use until the end of June.